FURESTEM-OA Kit Inj., a therapeutic biological product, is composed of allogeneic umbilical cord blood-derived mesenchymal stem cells (FURESTEM-OA Inj.), as a major active component for repairing tissue damage, and cartilage acellular matrix (CAM Inj.), a medical device, as a supportive material.
This convergence medical product is under development for the treatment of osteoarthritis patients with knee cartilage damage.
- Product name : FURESTEM-OA Kit Inj.
- Manufacturer : Kangstem Biotech
- Target : Osteoarthritis patients at ICRS grade 3 or 4
- Injection route : Intra-articular Injection/ Single Injection
: In combination of two components (FURESTEM-OA and CAM Inj.) the administered stem cells have the ability to differentiate into chondrocytes as well as being able to enhance inflammation modulation thus promoting osteoarthritic mitigation and cartilage regeneration.